APA (7th ed.) Citation

Tessier, S., Lipton, B. A., Arastu, M. I., Curiale, A. M., Longo, S., & Nanda, S. (2023). Long‐term low‐dose cabergoline usage: Another association with cardiac valvulopathy. Echocardiography, 40(1), 61. https://doi.org/10.1111/echo.15506

Chicago Style (17th ed.) Citation

Tessier, Steven, Brooke A. Lipton, Mohammad I. Arastu, Andrew M. Curiale, Santo Longo, and Sudip Nanda. "Long‐term Low‐dose Cabergoline Usage: Another Association with Cardiac Valvulopathy." Echocardiography 40, no. 1 (2023): 61. https://doi.org/10.1111/echo.15506.

MLA (9th ed.) Citation

Tessier, Steven, et al. "Long‐term Low‐dose Cabergoline Usage: Another Association with Cardiac Valvulopathy." Echocardiography, vol. 40, no. 1, 2023, p. 61, https://doi.org/10.1111/echo.15506.